ArticlebioRxiv : the preprint server for biology2025
Identification and characterization of functional and trans-dominant negative HERV-K (HML-2) Rec proteins encoded in the human genome.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Human Endogenous Retroviruses K (HERV-K) of the HML-2 subgroup are the most recently integrated and biologically active retroviral elements within the human genome. The HERV-K Rec protein, a functional homolog of HIV Rev and HTLV Rex, is necessary for the nuclear export of viral mRNAs with retained introns. However, the diversity of Rec proteins encoded in the human genome and their functional capacities have remained largely unexplored. We identified full-length Rec protein sequences in the human genome and selected 23 variants for functional characterization. Using a dual-color fluorescent reporter and a complementary ELISA assay, we found that Rec proteins from only 7 genomic loci were functional. In addition, a subset of the non-functional Rec proteins exerted trans-dominant negative effects. Detailed mutational analysis of the most potent inhibitory variant, encoded by the HERV-K provirus 12q14.1, displayed only 2 amino acid changes (H2N and del34E) relative to the prototypical functional Rec protein encoded by the reconstructed consensus HERV-K (HERV-K Con). Insertion of a glutamic acid at position 34 restored the functional activity, while the substitution of histidine with asparagine at position 2 did not. Our results unveil an unexpected complexity in HERV-K (HML-2) post-transcriptional regulation, with Rec variants displaying a spectrum of activities ranging from robust nuclear export of RNA with retained introns to trans-dominant negative inhibition of Rec function. These findings expand our understanding of the regulatory landscape governing HERV-K (HML-2) expression and suggest mechanisms by which different HERV-K Rec proteins may influence host cell biology and pathology, including oncogenesis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.